Literature DB >> 25674263

Ki-67/MIB-1 immunostaining in a cohort of human gliomas.

Anne J Skjulsvik1, Jørgen N Mørk2, Morten O Torp2, Sverre H Torp1.   

Abstract

Histopathological malignancy grading of human gliomas is limited by subjective interpretation of the morphological criteria. Assessment of mitotic activity is a cornerstone of grading these tumours, but mitotic figures can be hard to identify in haematoxylin-eosin stained sections. Thus, determining proliferative activity by means of Ki-67/MIB-1 immunostaining has become a useful supplement. However, this method has drawbacks, so continuous testing and evaluation are required for optimization and standardization. The aim of this study was to analyse and evaluate the Ki-67/MIB-1 proliferative indices (PIs) in a series of gliomas. We found that Ki-67/MIB-1 PIs correlated well with histological malignancy grade in all glioma subtypes, but a considerable overlap of PIs was observed between the malignancy groups. Consequently, Ki-67/MIB-1 immunostaining alone is not sufficient to adequately determine the malignancy grade. Therefore, future work is necessary to clarify the role of this immunostaining in the histopathological diagnosis of human gliomas.

Entities:  

Keywords:  Astrocytoma; brain tumour; diagnosis; glioblastoma; immunohistochemistry; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25674263      PMCID: PMC4313958     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen.

Authors:  K Wester; E Wahlund; C Sundström; P Ranefall; E Bengtsson; P J Russell; K T Ow; P U Malmström; C Busch
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-03

Review 2.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

Review 3.  Ki67 and proliferation in breast cancer.

Authors:  Nirmala Pathmanathan; Rosemary L Balleine
Journal:  J Clin Pathol       Date:  2013-02-22       Impact factor: 3.411

4.  Moving toward molecular classification of diffuse gliomas in adults.

Authors:  Brett J Theeler; W K Alfred Yung; Gregory N Fuller; John F De Groot
Journal:  Neurology       Date:  2012-10-30       Impact factor: 9.910

5.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Authors:  Mitch Dowsett; Torsten O Nielsen; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick; Matthew Ellis; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Christos Sotiriou; Ian E Smith; Giuseppe Viale; Jo Anne Zujewski; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2011-09-29       Impact factor: 13.506

6.  Comparative validation of the SP6 antibody to Ki67 in breast cancer.

Authors:  Lila Zabaglo; Janine Salter; Helen Anderson; Emma Quinn; Margaret Hills; Simone Detre; Roger A'Hern; Mitch Dowsett
Journal:  J Clin Pathol       Date:  2010-07-29       Impact factor: 3.411

7.  Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study.

Authors:  Andreas H Habberstad; Sasha Gulati; Sverre H Torp
Journal:  Diagn Pathol       Date:  2011-05-24       Impact factor: 2.644

Review 8.  Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.

Authors:  Elisabeth Luporsi; Fabrice André; Frédérique Spyratos; Pierre-Marie Martin; Jocelyne Jacquemier; Frédérique Penault-Llorca; Nicole Tubiana-Mathieu; Brigitte Sigal-Zafrani; Laurent Arnould; Anne Gompel; Caroline Egele; Bruno Poulet; Krishna B Clough; Hubert Crouet; Alain Fourquet; Jean-Pierre Lefranc; Carole Mathelin; Nicolas Rouyer; Daniel Serin; Marc Spielmann; Margaret Haugh; Marie-Pierre Chenard; Etienne Brain; Patricia de Cremoux; Jean-Pierre Bellocq
Journal:  Breast Cancer Res Treat       Date:  2011-11-03       Impact factor: 4.872

Review 9.  Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

Authors:  Nanne K Kloosterhof; Linda B C Bralten; Hendrikus J Dubbink; Pim J French; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2010-07-07       Impact factor: 54.433

10.  Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Authors:  Anna S Berghoff; Harald Stefanits; Adelheid Woehrer; Harald Heinzl; Matthias Preusser; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368

View more
  16 in total

1.  Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging.

Authors:  Evan D H Gates; Jonathan S Lin; Jeffrey S Weinberg; Jackson Hamilton; Sujit S Prabhu; John D Hazle; Gregory N Fuller; Veera Baladandayuthapani; David Fuentes; Dawid Schellingerhout
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

2.  Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.

Authors:  Sirui Li; Yuan Zheng; Wenbo Sun; Samo Lasič; Filip Szczepankiewicz; Qing Wei; Shihong Han; Shuheng Zhang; Xiaoli Zhong; Liang Wang; Huan Li; Yuxiang Cai; Dan Xu; Zhiqiang Li; Qiang He; Danielle van Westen; Karin Bryskhe; Daniel Topgaard; Haibo Xu
Journal:  Eur Radiol       Date:  2021-04-29       Impact factor: 5.315

3.  Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index.

Authors:  Ren Yan; Pang Haopeng; Feng Xiaoyuan; Wu Jinsong; Zhang Jiawen; Yao Chengjun; Qiu Tianming; Xiong Ji; Sheng Mao; Ding Yueyue; Zhang Yong; Luo Jianfeng; Yao Zhenwei
Journal:  Neuroradiology       Date:  2015-10-22       Impact factor: 2.804

4.  Monoexponential, biexponential and stretched exponential models of diffusion weighted magnetic resonance imaging in glioma in relation to histopathologic grade and Ki-67 labeling index using high B values.

Authors:  Nabin Chaudhary; Guiling Zhang; Shihui Li; Wenzhen Zhu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  Dichotomy in Growth and Invasion from Low- to High-Grade Glioma Cellular Variants.

Authors:  Krishnendu Ghosh; Samarendranath Ghosh; Uttara Chatterjee; Pritha Bhattacharjee; Anirban Ghosh
Journal:  Cell Mol Neurobiol       Date:  2021-05-12       Impact factor: 4.231

6.  Survivin and gliomas: A literature review.

Authors:  Rosilin Kotakkathu Varughese; Sverre Helge Torp
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

7.  Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation.

Authors:  George S Stoyanov; Deyan L Dzhenkov; Martina Kitanova; Ivan S Donev; Peter Ghenev
Journal:  Cureus       Date:  2017-06-26

8.  Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment.

Authors:  Nuria Arias-Ramos; Laura Ferrer-Font; Silvia Lope-Piedrafita; Victor Mocioiu; Margarida Julià-Sapé; Martí Pumarola; Carles Arús; Ana Paula Candiota
Journal:  Metabolites       Date:  2017-05-18

9.  Unique case of oligoastrocytoma with recurrence and grade progression: Exhibiting differential expression of high mobility group-A1 and human telomerase reverse transcriptase.

Authors:  Puneet Gandhi; Richa Khare; Kavita Niraj; Nitin Garg; Sandeep K Sorte; Hanni Gulwani
Journal:  World J Clin Cases       Date:  2016-09-16       Impact factor: 1.337

10.  Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.

Authors:  Zhun Wang; Hui Xie; Linpei Guo; Qiliang Cai; Zhiqun Shang; Ning Jiang; Yuanjie Niu
Journal:  Cancer Manag Res       Date:  2017-11-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.